Edesa Biotech, Inc. (EDSA)

NASDAQ: EDSA · Real-Time Price · USD

1.460

+0.040 (2.82%)

Jan 2, 2026, 11:49 AM EST - Market open

Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jan '26 Jan 2, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2017 - 2020
Market Capitalization	12	17	14	13	14	98	Upgrade
Market Cap Growth	81.24%	20.29%	8.40%	-6.42%	-85.44%	26.16%	Upgrade
Enterprise Value	1	14	12	7	1	90	Upgrade
Last Close Price	1.42	2.47	4.45	4.42	6.45	51.66	Upgrade
Forward PE	-	-	-	-	56.67	-	Upgrade
PB Ratio	3.18	1.40	7.29	1.89	1.52	7.49	Upgrade
P/TBV Ratio	9.75	14.32	-	2.74	2.00	9.16	Upgrade
Debt / Equity Ratio	-	-	0.01	0.01	0.00	0.01	Upgrade
Quick Ratio	10.60	10.60	0.71	3.29	3.90	7.64	Upgrade
Current Ratio	10.68	10.68	0.91	3.53	4.25	8.29	Upgrade
Return on Equity (ROE)	-99.57%	-99.57%	-136.66%	-101.88%	-156.34%	-120.39%	Upgrade
Return on Assets (ROA)	-57.02%	-57.02%	-69.02%	-56.33%	-87.78%	-116.79%	Upgrade
Return on Capital (ROIC)	-68.42%	-68.42%	-95.89%	-69.64%	-101.75%	-131.97%	Upgrade
Return on Capital Employed (ROCE)	-63.50%	-63.50%	-354.10%	-130.50%	-194.70%	-180.40%	Upgrade
Earnings Yield	-60.72%	-41.34%	-42.70%	-62.82%	-123.19%	-13.64%	Upgrade
FCF Yield	-61.87%	-42.12%	-33.84%	-49.78%	-86.24%	-13.98%	Upgrade
Buyback Yield / Dilution	-77.54%	-77.54%	-11.84%	-36.37%	-21.50%	-40.32%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q